Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Bladder-selective potassium channel openers described by Abbott and ICAgen

Sep. 4, 2002

Pharmacodynamic and pharmacokinetic profile of fesoterodine

Sep. 4, 2002

Potential new agent for stress urinary incontinence in development at Roche Bioscience

Sep. 3, 2002

Renal vasoconstriction induced by tacrolimus in rats is prevented by low dose theophylline

Aug. 29, 2002

Verapamil is effective in the treatment of Peyronie's disease

Aug. 28, 2002

New 5-HT2C agonist and its use in erectile dysfunction discussed at ACS meeting

Aug. 23, 2002

Potassium channel openers for use in bladder overactivity presented by Abbott at ACS

Aug. 22, 2002

Pivotal Alprox-TD studies complete enrollment

Aug. 21, 2002

SAR on novel PDE5 inhibitors reported by Pfizer

Aug. 19, 2002

New vasopressin V1a/V2 modulators for renal failure and hypertension

Aug. 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...